Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Clemens Scherzer, M.D.

Co-Author

This page shows the publications co-authored by Clemens Scherzer and Xianjun Dong.
Connection Strength

2.509
  1. Publisher Correction: Enhancers active in dopamine neurons are a primary link between genetic variation and neuropsychiatric disease. Nat Neurosci. 2019 Jan; 22(1):144-147.
    View in: PubMed
    Score: 0.818
  2. Enhancers active in dopamine neurons are a primary link between genetic variation and neuropsychiatric disease. Nat Neurosci. 2018 10; 21(10):1482-1492.
    View in: PubMed
    Score: 0.802
  3. powerEQTL: An R package and shiny application for sample size and power calculation of bulk tissue and single-cell eQTL analysis. Bioinformatics. 2021 May 19.
    View in: PubMed
    Score: 0.241
  4. Genome-wide survival study identifies a novel synaptic locus and polygenic score for cognitive progression in Parkinson's disease. Nat Genet. 2021 06; 53(6):787-793.
    View in: PubMed
    Score: 0.241
  5. ß2-Adrenoreceptor is a regulator of the a-synuclein gene driving risk of Parkinson's disease. Science. 2017 09 01; 357(6354):891-898.
    View in: PubMed
    Score: 0.186
  6. Association between a-synuclein blood transcripts and early, neuroimaging-supported Parkinson's disease. Brain. 2015 Sep; 138(Pt 9):2659-71.
    View in: PubMed
    Score: 0.161
  7. Accelerating Medicines Partnership: Parkinson's Disease. Genetic Resource. Mov Disord. 2021 08; 36(8):1795-1804.
    View in: PubMed
    Score: 0.060
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.